Inari Medical, Inc.(NARI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NARI Inari Medical, Inc.

Market Closed 05-17 16:00:00 EDT

45.75

-0.55

-1.19%

盘后45.75

+0.000.00%

16:58 EDT

High46.52	Low45.69	Vol887.81K
Open46.33	D1 Closing46.30	Amplitude1.78%
Mkt Cap2.66B	Tradable Cap2.27B	Total Shares58.14M
T/O40.86M	T/O Rate1.79%	Tradable Shares49.67M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"NARI","market":"US","secType":"STK","nameCN":"Inari Medical, Inc.","latestPrice":45.75,"timestamp":1715976000000,"preClose":46.3,"halted":0,"volume":887809,"hourTrading":{"tag":"盘后","latestPrice":45.75,"preClose":45.75,"latestTime":"16:58 EDT","volume":56599,"amount":2589410.54,"timestamp":1715979492140},"delay":0,"floatShares":49672748,"shares":58138159,"eps":-0.414251,"marketStatus":"Market Closed","change":-0.55,"latestTime":"05-17 16:00:00 EDT","open":46.33,"high":46.515,"low":45.69,"amount":40858452.82103,"amplitude":0.017819,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.414251,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1716192000000},"marketStatusCode":7,"adr":0,"listingDate":1590120000000,"exchange":"NASDAQ","adjPreClose":46.3,"preHourTrading":{"tag":"盘前","latestPrice":46.09,"preClose":46.3,"latestTime":"08:32 EDT","volume":86,"amount":3963.7400000000002,"timestamp":1715949171298},"postHourTrading":{"tag":"盘后","latestPrice":45.75,"preClose":45.75,"latestTime":"16:58 EDT","volume":56599,"amount":2589410.54,"timestamp":1715979492140},"volumeRatio":0.8648730845991979},"requestUrl":"/m/hq/s/NARI","defaultTab":"news","newsList":[{"id":"2436088759","title":"Insider Sale: Director William Hoffman Sells 40,000 Shares of Inari Medical Inc (NARI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2436088759","media":"GuruFocus.com","top":-1,"share":"https://ttm.financial/m/news/2436088759?lang=en_us&edition=fundamental","pubTime":"2024-05-18 14:36","pubTimestamp":1716014219,"startTime":"0","endTime":"0","summary":"On May 16, 2024, Director William Hoffman of Inari Medical Inc  executed a sale of 40,000 shares of the company's stock. The transaction was filed with the SEC and can be viewed in detail through the SEC Filing.GuruFocus has detected 4 Warning Signs with NARI.Inari Medical Inc is a medical device company focused on developing products for the treatment of venous diseases. The company's product portfolio includes devices designed to remove blood clots and other obstructions from the venous system.The shares were sold at a price of $46.6 each, resulting in a total transaction amount of $1,864,000. This sale by the insider has followed a pattern over the past year, where William Hoffman has sold a total of 295,000 shares and has not made any purchases.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ks87HEqGdEOqQXnrkaJtGw--~B/aD01NDM7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/39bb030b57dd72d4c4a58ee5f3076268","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ks87HEqGdEOqQXnrkaJtGw--~B/aD01NDM7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/39bb030b57dd72d4c4a58ee5f3076268"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insider-sale-director-william-hoffman-063659665.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2434043188","title":"Novo Nordisk, Flagship to develop next-generation obesity drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2434043188","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2434043188?lang=en_us&edition=fundamental","pubTime":"2024-05-10 01:22","pubTimestamp":1715275348,"startTime":"0","endTime":"0","summary":"Flagship Pioneering’s Metaphore unit announced a new collaboration with partner Novo Nordisk (NVO) for the research and development of next-generation obesity management treatments. The collaboration ","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1219304819/image_1219304819.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1219304819/image_1219304819.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4103937-novo-nordisk-flagship-to-develop-next-generation-obesity-drugs","is_publish_highlight":false,"gpt_icon":0},{"id":"2433425530","title":"Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2433425530","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2433425530?lang=en_us&edition=fundamental","pubTime":"2024-05-06 11:00","pubTimestamp":1714964400,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., May  06, 2024  (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from ven","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/06/2875674/0/en/Inari-Medical-to-Participate-in-the-2024-Bank-of-America-Securities-Healthcare-Conference.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432920191","title":"Baron Discovery Fund Q1 2024 Shareholder Letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2432920191","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2432920191?lang=en_us&edition=fundamental","pubTime":"2024-05-03 19:15","pubTimestamp":1714734900,"startTime":"0","endTime":"0","summary":"Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing.During the first quarter of 2024, Bar","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4688998-baron-discovery-fund-q1-2024-shareholder-letter","is_publish_highlight":false,"gpt_icon":1},{"id":"2432697951","title":"Inari Medical, Inc. (NASDAQ:NARI) Just Reported, And Analysts Assigned A US$66.00 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2432697951","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2432697951?lang=en_us&edition=fundamental","pubTime":"2024-05-03 19:11","pubTimestamp":1714734700,"startTime":"0","endTime":"0","summary":"Investors in Inari Medical, Inc.  had a good week, as its shares rose 9.3% to close at US$41.99 following the release of its first-quarter results. Revenues of US$143m beat expectations by a respectable 3.9%, although statutory losses per share increased. Inari Medical lost US$0.42, which was 118% more than what the analysts had included in their models. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.The most important thing to note is the forecast of increased losses next year, suggesting all may not be well at Inari Medical. Fortunately, they also re","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inari-medical-inc-nasdaq-nari-111140917.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432761306","title":"Inari Medical First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2432761306","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2432761306?lang=en_us&edition=fundamental","pubTime":"2024-05-02 18:35","pubTimestamp":1714646117,"startTime":"0","endTime":"0","summary":"NasdaqGS:NARI Earnings and Revenue Growth May 2nd 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 3.9%. Earnings per share  missed analyst estimates by 118%.Looking ahead, revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 8.1% growth forecast for the Medical Equipment industry in the US.The company's shares are up 9.0% from a week ago.We don't want to rain on the parade too much, but we did also find 1 warning sign for Inari Medical that you need to be mindful of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inari-medical-first-quarter-2024-103517813.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432683589","title":"Inari Medical (NARI) Q1 Earnings Miss Estimates, OpEx Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2432683589","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2432683589?lang=en_us&edition=fundamental","pubTime":"2024-05-01 22:59","pubTimestamp":1714575540,"startTime":"0","endTime":"0","summary":"Inari Medical, Inc.NARI reported an adjusted loss per share of 26 cents in the first quarter of 2024 compared with the year-ago period’s loss of 4 cents per share. The Zacks Consensus Estimate for loss per share was pegged at 11 cents. On a GAAP basis, the company recorded a loss per share of 42 cents. There was no adjustment in the prior-year period.Inari Medical registered revenues of $143.2 million in the first quarter, up 23.3% year over year. The figure beat the Zacks Consensus Estimate by 3.5%.Shares of Inari Medical were up 12.5% in pre-market trading on May 1 following better-than-expected quarterly results. The stock has lost 37.8% in the past year against theindustry’s 2.9% growth. The broader S&P 500 Index has moved up 23.2% in the past year.The operating loss totaled $17.2 million compared with $5.3 million in the year-ago period. Excluding acquisition-related costs of $2.8 million, acquired intangible asset amortization of $2.5 million and change in fair value of contingen","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Op4XXCiuaZt42C3BmkzkNw--~B/aD0zNDk7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e729d5a07f148302369676bf26b14bf7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Op4XXCiuaZt42C3BmkzkNw--~B/aD0zNDk7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e729d5a07f148302369676bf26b14bf7"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inari-medical-nari-q1-earnings-145900093.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432157492","title":"Bank of America Securities Sticks to Their Buy Rating for Inari Medical (NARI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2432157492","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2432157492?lang=en_us&edition=fundamental","pubTime":"2024-05-01 21:06","pubTimestamp":1714568765,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Travis Steed maintained a Buy rating on Inari Medical (NARI – Research Report) today. The company’s shares close...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-their-buy-rating-for-inari-medical-nari?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-their-buy-rating-for-inari-medical-nari?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2432579096","title":"Inari Medical Shares Climb After Outlook Raise, Strong 1Q Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2432579096","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2432579096?lang=en_us&edition=fundamental","pubTime":"2024-05-01 20:55","pubTimestamp":1714568100,"startTime":"0","endTime":"0","summary":"Shares of Inari Medical jumped after the company raised its 2024 revenue guidance and beat analysts' top line expectations for the first quarter.The stock was up 11% at $41.42 in premarket trading. Shares had fallen 43% year-to-date when the market closed Tuesday.The medical device company said late on Tuesday it expected $592.5 million to $602.5 million in revenue this year, up from previous guidance of $580 million to $595 million.Analysts polled by FactSet had been expecting $588.3 million prior to the revision.For the first three months of the year, Inari posted revenue of $143.2 million, up from $116.2 million in the year-ago quarter and topping analyst projections for $137.8 million.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2432571431","title":"IMTE, HKIT and AGBA are among premarket gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2432571431","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2432571431?lang=en_us&edition=fundamental","pubTime":"2024-05-01 20:54","pubTimestamp":1714568072,"startTime":"0","endTime":"0","summary":"Gainers: Palisade Bio  +56% Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide   TG Therapeutics  +28% Q1 earnings call release  Root  +26% Q1 earnings call release  Predictive Oncology  +26% stock rallies 30% post-market on vaccine collaboration  DecisionPoint Systems  +24% Systems to go private in all-cash deal.  Plutonian Acquisition  +24%. New York Community Bancorp  +20% Q1 earnings call release  Pinterest  +16% Q1 earnings call release  Transmedics Group  +15% Q1 earnings call release  AGBA Group Holding  +9%. Inari Medical  +10% Q1 earnings call release  Integrated Media Technology  +10%. Ashford Hospitality Trust  +9% Q1 earnings call release  NexGen Energy  +9% surge as U.S. Senate passes bill banning Russian imports  Hitek Global  +9%.","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4097247-imte-hkit-and-agba-are-among-premarket-gainers","is_publish_highlight":false,"gpt_icon":0},{"id":"2432952750","title":"Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Inari Medical (NARI) and Tenet Healthcare (THC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2432952750","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2432952750?lang=en_us&edition=fundamental","pubTime":"2024-05-01 19:20","pubTimestamp":1714562456,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Merit Medical Systems (MMSI – Research Report), Inari Medical (NA...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merit-medical-systems-mmsi-inari-medical-nari-and-tenet-healthcare-thc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merit-medical-systems-mmsi-inari-medical-nari-and-tenet-healthcare-thc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2432434335","title":"Inari Medical Inc (NARI) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2432434335","media":"GuruFocus.com","top":-1,"share":"https://ttm.financial/m/news/2432434335?lang=en_us&edition=fundamental","pubTime":"2024-05-01 15:30","pubTimestamp":1714548625,"startTime":"0","endTime":"0","summary":"Q1 2024 Revenue: $143.2 million, up 23.3% year-over-year. Global VT Revenue: $137.2 million, up 20.3% year-over-year. Emerging Therapies Revenue: $6 million, up 184.5% year-over-year. Operating Expenses: $141.5 million, up from $107.8 million year-over-year. GAAP Operating Loss: $17.2 million, compared to $5.3 million year-over-year. Net Loss: $24.2 million, compared to $2.2 million year-over-year. Net Loss Per Share: $0.42, compared to $0.04 year-over-year. Cash and Investments: $102 million at the end of Q1 2024. 2024 Revenue Guidance: Raised to $592.5 million to $602.5 million. GuruFocus has detected 5 Warning Signs with NARI.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inari-medical-inc-nari-q1-073025617.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"https://www.inarimedical.com","stockEarnings":[{"period":"1week","weight":0.0457},{"period":"1month","weight":0.1822},{"period":"3month","weight":-0.2171},{"period":"6month","weight":-0.2109},{"period":"1year","weight":-0.3143},{"period":"ytd","weight":-0.2953}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.081523},{"month":2,"riseRate":0.5,"avgChangeRate":0.022055},{"month":3,"riseRate":1,"avgChangeRate":0.047729},{"month":4,"riseRate":0.5,"avgChangeRate":-0.046873},{"month":5,"riseRate":0.25,"avgChangeRate":-0.072314},{"month":6,"riseRate":0.75,"avgChangeRate":0.042394},{"month":7,"riseRate":0.5,"avgChangeRate":0.061461},{"month":8,"riseRate":0.5,"avgChangeRate":0.098713},{"month":9,"riseRate":0.25,"avgChangeRate":-0.02919},{"month":10,"riseRate":0.5,"avgChangeRate":0.01566},{"month":11,"riseRate":0.25,"avgChangeRate":-0.026288},{"month":12,"riseRate":0.75,"avgChangeRate":0.08025}],"exchange":"NASDAQ","name":"Inari Medical, Inc.","nameEN":"Inari Medical, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inari Medical, Inc.(NARI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Inari Medical, Inc.(NARI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Inari Medical, Inc.,NARI,Inari Medical, Inc.股票,Inari Medical, Inc.股票老虎,Inari Medical, Inc.股票老虎国际,Inari Medical, Inc.行情,Inari Medical, Inc.股票行情,Inari Medical, Inc.股价,Inari Medical, Inc.股市,Inari Medical, Inc.股票价格,Inari Medical, Inc.股票交易,Inari Medical, Inc.股票购买,Inari Medical, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inari Medical, Inc.(NARI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Inari Medical, Inc.(NARI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}